查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1464966

腦腫瘤和脊髓癌市場：按腫瘤類型、治療方法和最終用戶分類 - 全球預測 2024-2030

Brain & Spinal Cord Cancer Market by Tumor Type (Glioblastoma, Meningioma, Pituitary Tumors), Treatment (Diagnosis, Therapeutics), End-users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年腦瘤和脊髓癌市場規模為37.7億美元，2024年達39.8億美元，預計2030年將達到55.9億美元，複合年成長率為5.75%。

腦癌和脊髓癌是當惡性（癌）細胞在腦或脊髓組織中生長時發生的中樞神經系統癌症。這些癌症會損害這些區域控制的重要功能，例如肌肉控制、感覺、記憶和其他認知能力。腦癌和脊髓癌的治療計劃根據每個人的具體情況量身定做，可能包括手術、放射線治療、化療、標靶治療或這些治療的組合。該市場的應用涵蓋各個醫學領域，包括神經腫瘤學、神經外科、放射學和安寧療護。最終使用者通常是需要診斷、治療和支持性護理服務的患者，以及醫院、診所和專門癌症治療中心等醫療機構。影響腦癌和脊髓癌治療需求的因素包括醫療技術的進步、腦癌和脊髓癌盛行率的上升、醫療基礎設施投資的增加以及對這些疾病的認知。然而，市場面臨某些挑戰，包括治療成本上升、獲得先進醫療設施的機會有限，以及對腦癌和脊髓癌複雜性的擔憂。另一方面，將人工智慧和機器學習引入診斷過程，以及人們對基於基因圖譜的個人化醫療的日益偏好，正在為腦腫瘤和脊椎癌市場創造潛在機會。

主要市場統計
基準年[2023] 37.7億美元
預測年份 [2024] 39.8億美元
預測年份 [2030] 55.9億美元
複合年成長率（%） 5.75%

治療

診斷是癌症治療的基石，準確的識別對於有效的治療策略至關重要。對於腦癌和脊髓癌，主要使用診斷影像和切片檢查。 電腦斷層掃描、MRI 和正子斷層掃描 (PET) 掃描等先進影像方式在診斷腦癌和脊髓癌方面發揮重要作用。切片檢查，包括針吸活體組織切片和開放切片檢查，透過分析組織樣本來確認癌症的存在。腦癌和脊髓癌的治療採用多方面的治療方法，包括手術、放射線治療、化療和標靶治療。手術通常是切除腫瘤的首選治療方法。另一種重要的治療方法是放射線治療，它使用高能量射線來破壞癌細胞。化療使用藥物殺死癌細胞，通常與其他治療方法結合。標靶治療是一種新型癌症治療方法，特異性針對癌細胞而不傷害正常細胞。根據腫瘤類型、分期和患者健康狀況，治療方法選擇是高度個人化的。對於局部腫瘤，優選手術或放射線治療來切除或縮小腫瘤。相反，化療和標靶治療有利於治療全身性疾病和無法手術的腫瘤。

最終用戶

門診手術中心 (ASC) 在腦癌和脊髓癌的治療中變得越來越重要，為患者提供恢復時間短的微創手術選擇。對於患者病情穩定且手術複雜程度為輕度至中度的病例，這些中心是首選。這些中心強調成本效益、病人便利性和快速出院。診斷中心在腦腫瘤和脊髓癌的早期診斷中發揮重要作用。這些設施配備了先進的診斷影像技術，包括 MRI、 電腦斷層掃描和 PET 掃描，這對於準確的診斷和治療計劃至關重要。患者和醫療保健提供者通常更喜歡提供先進技術、快速診斷時間和優質影像服務的專業診斷中心。醫院和診所是腦癌和脊髓癌患者最全面的醫療保健機構，提供從診斷到手術、放射線治療和化療等高級治療方法的廣泛服務。這些醫院因其交通方便、多學科團隊以及處理複雜病例和緊急情況的能力而受到青睞。儘管這三個領域在腦癌和脊髓癌患者的持續照護中都發揮著重要作用，但他們基於需求的偏好存在明顯差異。由於 ASC 的效率和成本效益，它是不太複雜的手術需求的首選。診斷中心對於使用先進的影像技術進行早期、準確的診斷至關重要。然而，醫院和診所處理最複雜和緊急的病例，提供最廣泛的服務，並擁有綜合多學科護理團隊的優勢。

區域洞察

美洲，特別是美國和加拿大，正在對研發進行大量投資，以推進腦癌和脊髓癌的治療。高昂的醫療成本以及大型醫療機構和生物技術公司的存在正在推動先進的研究舉措，包括精準醫學和新型療法。在南美洲，由於醫療成本上升、癌症發病率增加以及醫療基礎設施改善緩慢，巴西和阿根廷在腦癌和脊髓癌的治療方面進展緩慢。歐盟國家擁有強大的醫療基礎設施，多項癌症研究和早期檢測舉措正在進行中。公共和私營部門對醫學研究的資助不斷增加，正在帶來重大突破。該地區的患者受益於全民健康保險體系並獲得先進的治療。中東和非洲地區面臨獨特的挑戰，包括醫療基礎設施的變化和可近性問題。重點逐漸轉向改善醫療設施和癌症治療中心，政府和非政府組織扮演重要角色。在中國、日本和印度等國家經濟成長的推動下，亞太地區正見證醫療保健產業的快速轉型。這些國家的醫療支出正在快速成長，並且處於癌症治療技術創新的前沿。消費者對優質癌症照護的認知和需求很高，導致政府和私人對醫療基礎設施和研究計畫的投資增加。

FPNV定位矩陣

FPNV定位矩陣對於評估腦腫瘤和脊椎癌市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對腦腫瘤和脊椎癌市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.腦腫瘤/脊髓癌市場的市場規模和預測是多少？

2.在腦腫瘤和脊髓癌市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.腦腫瘤/脊髓癌市場的技術趨勢和法規結構是什麼？

4.腦腫瘤/脊髓癌市場主要廠商的市場佔有率是多少？

5.進入腦腫瘤/脊髓癌市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球腦和脊髓腫瘤的發生率增加
      • 隨著人們對這些疾病的認知不斷提高，對醫療保健基礎設施的投資也增加
      • 政府繼續努力進行癌症研究和早期檢測
    • 抑制因素
      • 腦癌和脊髓癌的治療費用很高，並且獲得先進醫療設施的機會有限。
    • 機會
      • 將人工智慧和機器學習納入診斷過程
      • 人們對基於基因圖譜的個人化醫療越來越感興趣
    • 任務
      • 對腦癌和脊髓癌複雜性的擔憂
  • 市場區隔分析

第 5 章 2.1。

第 5 章 2.2。

  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章依腫瘤類型分類的腦腫瘤/脊髓癌市場

  • 神經膠母細胞瘤
  • 腦膜瘤
  • 腦下垂體瘤

第7章依治療分類的腦腫瘤/脊髓癌市場

  • 診斷
  • 治療藥物

第8章腦腫瘤/脊髓癌市場：依最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院/診所

第9章北美和南美腦腫瘤和脊髓癌市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區腦腫瘤與脊髓癌市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的腦腫瘤和脊髓癌市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Diaconos 腦腫瘤疫苗獲得 FDA 孤兒藥稱號
    • 諾華公司的 Tafinlar + Mekinist 已獲得 FDA核准用於患有 BRAF V600E 低惡性神經膠質瘤（最常見的兒童腦瘤）的兒童患者。
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-9E71DF483B96

[187 Pages Report] The Brain & Spinal Cord Cancer Market size was estimated at USD 3.77 billion in 2023 and expected to reach USD 3.98 billion in 2024, at a CAGR 5.75% to reach USD 5.59 billion by 2030.

Brain and spinal cord cancers are types of central nervous system cancers that occur when malignant (cancer) cells grow in the brain or spinal cord tissue. These cancers can disrupt the vital functions controlled by these areas, including muscle control, sensation, memory, and other cognitive abilities. Treatment plans for brain and spinal cord cancers are tailored to each individual's specific condition and may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these. This market's applications span across various medical fields, including neuro-oncology, neurosurgery, radiology, and palliative care. End-users are typically healthcare facilities such as hospitals, clinics, and specialized cancer treatment centers, besides patients requiring diagnostic, therapeutic, and supportive care services. Factors influencing the need for brain and spinal cord cancer treatment include advancements in medical technology, rising prevalence of brain and spinal cord cancers, increased investment in healthcare infrastructure, and awareness about these conditions. However, the market faces certain challenges, such as high treatment costs, limited accessibility to advanced healthcare facilities, and concerns associated with the complex nature of brain and spinal cord cancers. On the other hand, the incorporation of AI and machine learning in diagnostic processes and increasing preference for personalized medicine based on genetic profile present potential opportunities for the brain and spinal cord cancers market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.77 billion
Estimated Year [2024] USD 3.98 billion
Forecast Year [2030] USD 5.59 billion
CAGR (%) 5.75%

Treatment:

Diagnosis forms the cornerstone of cancer treatment, with accurate identification pivotal for effective management strategies. For brain and spinal cord cancers, diagnosis primarily involves imaging techniques and biopsy procedures. Advanced imaging methods, including CT scans, MRI, and Positron Emission Tomography (PET) scans, play a vital role in diagnosing brain and spinal cord cancers. Biopsies, including needle biopsy and open biopsy, are employed to confirm the presence of cancer through tissue sample analysis. The therapy of brain and spinal cord cancers involves a multi-faceted therapeutic approach, including surgery, radiation therapy, chemotherapy, and targeted therapy. Surgery is often the first line of treatment aimed at tumor removal. Another critical treatment modality is radiation therapy, which employs high-energy rays to destroy cancer cells. Chemotherapy utilizes drugs to kill cancer cells and is often used in conjunction with other treatments. Targeted therapy represents a newer class of cancer treatment that specifically targets cancerous cells without harming normal ones. The selection of a therapeutic approach is highly individualized, based on tumor type, stage, and patient health. Surgery and radiation therapy are preferred for localized tumors to remove or decrease tumor size. In contrast, chemotherapy and targeted therapy are beneficial for managing systemic disease or tumors that are inoperable.

End-users:

Ambulatory surgical centers (ASCs) have become increasingly important in the cure of brain and spinal cord cancer, offering patients minimally invasive surgery options with shorter recovery times. These centers are preferred for cases where the patient's condition is stable and the complexity of the surgery is low to moderate. They emphasize cost-effectiveness, patient convenience, and quick discharge. Diagnostic centers play a critical role in the initial stages of diagnosing brain and spinal cord cancer. These facilities are equipped with advanced imaging technologies including MRI, CT scans, and PET scans, vital for accurate diagnosis and treatment planning. Patients and healthcare providers often prefer specialized diagnostic centers for their advanced technology, quick turnaround times, and high-quality imaging services. Hospitals and clinics are the most comprehensive providers for brain and spinal cord cancer patients, offering various services from diagnosis to advanced treatment options, including surgery, radiation therapy, and chemotherapy. They are preferred for their accessibility, multidisciplinary teams, and ability to handle complex cases and emergencies. While all three segments play vital roles in the continuum of care for brain and spinal cord cancer patients, there are distinct differences in their need-based preferences. ASCs are preferred for their efficiency and cost-effectiveness for less complex surgical needs. Diagnostic centers are critical for early and accurate diagnosis, leveraging advanced imaging technologies. Hospitals and clinics, however, offer the broadest range of services, catering to the most complex and emergent cases, and have the advantage of integrated, multidisciplinary care teams.

Regional Insights

In the Americas, particularly in the United States and Canada, significant investments in research and development have been made to advance the treatment of brain and spinal cord cancers. High healthcare expenses and the presence of major healthcare institutions and biotech firms have propelled advanced research initiatives, including precision medicine and novel therapeutics. In South America, Brazil and Argentina are witnessing moderate development in the treatment of the brain and spinal cord cancer market due to rising healthcare expenditure, increasing incidence of cancer, and gradual improvements in healthcare infrastructure. The EU countries boast a robust healthcare infrastructure and several ongoing initiatives for cancer research and early detection. Increased funding from both public and private sectors towards healthcare research has led to significant breakthroughs. Patients in this region benefit from universal healthcare systems, influencing their ability to access advanced treatments. The Middle East and Africa region encounters unique challenges, including variable healthcare infrastructure and accessibility issues. The focus is gradually shifting towards improving healthcare facilities and cancer care centers, with several governments and NGOs playing a pivotal role. The APAC region is witnessing a rapid transformation in the healthcare sector, driven by growing economies such as China, Japan, and India. These countries have seen a surge in healthcare spending and are at the forefront of technological innovation in cancer treatment. Consumer awareness and demand for quality cancer care are high, leading to greater government and private investment in healthcare infrastructure and research initiatives.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Brain & Spinal Cord Cancer Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brain & Spinal Cord Cancer Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Brain & Spinal Cord Cancer Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Bayer AG, bluebird bio, Inc., Bristol Myers Squibb Company, Dr. Reddy's Laboratories Ltd., Eisai Inc., F. Hoffmann-La Roche Ltd., Genentech, Inc., GlaxoSmithKline PLC, Illumina, Inc., Johnson & Johnson Services, Inc, Merck & Co., Inc., Nektar Therapeutics, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Shimadzu Corporation, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., and Y-mAbs Therapeutics A/S.

Market Segmentation & Coverage

This research report categorizes the Brain & Spinal Cord Cancer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Tumor Type
    • Glioblastoma
    • Meningioma
    • Pituitary Tumors
  • Treatment
    • Diagnosis
      • Cerebral Arteriogram
      • CT Scan
      • EEG
      • Lumbar Puncture
      • Molecular Testing
      • MRI
      • PET-CT Scan
      • Tissue Sampling
    • Therapeutics
      • Chemotherapy
      • Immunotherapy
      • Radiation Therapy
      • Surgery
      • Targeted Therapy
  • End-users
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Hospital & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Brain & Spinal Cord Cancer Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brain & Spinal Cord Cancer Market?

3. What are the technology trends and regulatory frameworks in the Brain & Spinal Cord Cancer Market?

4. What is the market share of the leading vendors in the Brain & Spinal Cord Cancer Market?

5. Which modes and strategic moves are suitable for entering the Brain & Spinal Cord Cancer Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of brain and spinal cord cancers globally
      • 5.1.1.2. Increased investment in healthcare infrastructure with growing awareness about these conditions
      • 5.1.1.3. Ongoing government initiatives aimed at cancer research and early detection
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment costs and limited accessibility to advanced healthcare facilities for brain and spinal cord cancer
    • 5.1.3. Opportunities
      • 5.1.3.1. Incorporation of AI and machine learning in diagnostic processes
      • 5.1.3.2. Increasing preference for personalized medicine based on genetic profile
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the complex nature of brain and spinal cord cancers
  • 5.2. Market Segmentation Analysis

5.2.1. Treatment:

5.2.2. End-users:

  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Brain & Spinal Cord Cancer Market, by Tumor Type

  • 6.1. Introduction
  • 6.2. Glioblastoma
  • 6.3. Meningioma
  • 6.4. Pituitary Tumors

7. Brain & Spinal Cord Cancer Market, by Treatment

  • 7.1. Introduction
  • 7.2. Diagnosis
  • 7.3. Therapeutics

8. Brain & Spinal Cord Cancer Market, by End-users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Centers
  • 8.4. Hospital & Clinics

9. Americas Brain & Spinal Cord Cancer Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brain & Spinal Cord Cancer Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brain & Spinal Cord Cancer Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Diakonos' brain tumor vaccine receives FDA's orphan drug designation
    • 12.3.2. Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BRAIN & SPINAL CORD CANCER MARKET RESEARCH PROCESS
  • FIGURE 2. BRAIN & SPINAL CORD CANCER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BRAIN & SPINAL CORD CANCER MARKET DYNAMICS
  • FIGURE 7. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BRAIN & SPINAL CORD CANCER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BRAIN & SPINAL CORD CANCER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BRAIN & SPINAL CORD CANCER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PITUITARY TUMORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PITUITARY TUMORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CT SCAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CT SCAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EEG, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EEG, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MRI, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MRI, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PET-CT SCAN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 316. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 323. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
  • TABLE 324. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
  • TABLE 325. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 326. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY BRAIN & SPINAL CORD CANC